COMMON STOCK (Details)
|
9 Months Ended |
Sep. 30, 2021
USD ($)
$ / shares
shares
|
Options Outstanding |
|
Number of Options/Warrants Outstanding, Beginning |
1,405,000
|
Number of Options/Warrants Outstanding, Granted |
2,880,000
|
Number of Options/Warrants Outstanding, Exercised |
(10,000)
|
Number of Options/Warrants Outstanding, Ending |
4,275,000
|
Number of Options Outstanding, Exercisable Ending |
1,395,000
|
Weighted Average Exercise Price, Beginning | $ / shares |
$ 0.24
|
Weighted Average Exercise Price, Granted | $ / shares |
0.13
|
Weighted Average Exercise Price, Exercised | $ / shares |
0.15
|
Weighted Average Exercise Price, Exercisable | $ / shares |
0.15
|
Weighted Average Exercise Price, Ending | $ / shares |
$ 0.24
|
Weighted Average Remaining Contractual Term in Years, Beginning |
7 years 8 months 12 days
|
Weighted Average Remaining Contractual Term in Years, Granted |
10 years
|
Weighted Average Remaining Contractual Term in Years, Exercised |
0 years
|
Weighted Average Remaining Contractual Term in Years, Ending |
9 years
|
Weighted Average Remaining Contractual Term in Years, Exercisable Ending |
6 years 10 months 24 days
|
Aggregate Intrinsic Value, Beginning | $ |
$ 0
|
Aggregate Intrinsic Value, Ending | $ |
$ 0
|
Nonvested Options |
|
Number of Options Nonvested, Beginning |
0
|
Number of Options Nonvested, Granted |
2,800,000
|
Number of Options Nonvested, Vested |
0
|
Number of Options Nonvested, Ending |
2,800,000
|
Weighted Average grant date Fair Value Nonvested, Beginning | $ / shares |
$ 0
|
Weighted Average grant date Fair Value Nonvested, Vested | $ / shares |
0
|
Weighted Average grant date Fair Value Nonvested, Ending | $ / shares |
$ 0
|
Weighted Average Remaining Years to vest Nonvested, Beginning |
0 years
|
Weighted Average Remaining Years to vest Nonvested, Granted |
3 years
|
Weighted Average Remaining Years to vest Nonvested, Ending |
3 years
|